Noveris Health Sciences is trading at CA$0.07, up +7.14%, with no clear catalyst identified.
- No October 13 company announcement surfaced in the latest available release listings; the latest listed release was the September 9 annual-meeting update.
- Available evidence does not establish a sector or broad-market explanation. Major-index readings provided were mixed, and no trading-volume figure was provided.